上海新阳(300236) - 2024 Q1 - 季度财报(更正)

Financial Performance - The company's operating revenue for Q1 2024 was ¥297,418,597.54, an increase of 14.01% compared to ¥260,864,353.08 in the same period last year[2] - Net profit attributable to shareholders decreased by 66.52% to ¥18,881,851.47 from ¥56,396,751.69 year-on-year[3] - Basic earnings per share dropped by 66.50% to ¥0.0610 from ¥0.1821 in the same period last year[3] - The company reported a total comprehensive income of -¥413,815,961.47 for the current period, compared to ¥670,128,143.99 in the previous period[20] - Net profit for the current period was $32,706,384.20, down 43% from $56,743,483.96 in the previous period[15] Cash Flow - The net cash flow from operating activities was negative at ¥-15,822,300.96, a decline of 168.33% compared to ¥-5,896,658.28 in the previous year[3] - Cash flow from operating activities generated ¥276,907,771.44, compared to ¥262,705,035.10 in the previous period, reflecting an increase[21] - Cash outflow for operating activities was $294,149,298.97, compared to $281,184,715.54 in the prior period, indicating increased expenses[25] - Net cash flow from investment activities was -$31,673,191.44, compared to -$20,673,208.14 in the previous year, indicating increased outflows[25] - Financing cash inflow reached $86,332,702.68, down from $140,113,060.00 in the last period[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,095,196,794.22, down 8.83% from ¥5,588,589,806.19 at the end of the previous year[3] - Total current assets decreased to ¥1,954,666,657.93 from ¥1,977,159,859.12, a decline of approximately 1.12%[8] - Total liabilities decreased to ¥1,261,861,311.90 from ¥1,360,963,878.47, a decline of approximately 7.25%[10] - Non-current assets decreased to ¥3,138,142,745.59 from ¥3,611,429,947.07, a decline of approximately 13.09%[9] - Total equity decreased to ¥3,830,948,091.62 from ¥4,227,625,927.72, a decrease of about 9.38%[10] Expenses - Total operating costs increased to $262,320,736.30, up from $239,832,538.62, reflecting a rise of approximately 9%[14] - Research and development expenses rose significantly to $46,113,719.49, compared to $30,489,905.47, marking a 51% increase[15] - The financial expenses for the reporting period were ¥127,072.90, a decrease of 141.80% compared to the previous year's income of ¥-304,029.38[7] - The income tax expense decreased by 63.29% to ¥4,344,077.54 from ¥11,833,761.11 year-on-year, reflecting a reduction in profit[7] Corrections and Compliance - The company held multiple meetings to approve the correction of the Q1 2024 report, ensuring compliance with legal and regulatory requirements[26] - The audit committee concluded that the corrected information provides a more objective and fair reflection of the company's financial status and operating results[26] - Independent directors unanimously agreed that the corrections do not harm the legitimate interests of the company and its shareholders[26] - The supervisory board confirmed that the review and voting procedures for the correction comply with relevant regulations and do not harm the interests of all shareholders[26] - The company expressed apologies for any inconvenience caused to investors due to the correction[27]